Login
← Go Back
Supriya Lifescience
SUPRIYA · Pharma > Pharmaceuticals & Drugs · Chairman: Satish Waman Wagh · MD: Satish Waman Wagh · Listing date: Dec. 29, 2021
Stock Price vs Company Growth
1d
1.7%
1w
1.7%
1m
0.5%
3m
2.8%
6m
2.2%
1y
3.4%
all
12.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 751 1.7%
684
831
Company Overview
Sales
715 Cr
Growth: 8.6%
Profit after Tax
182 Cr
Growth: 2.4%
Small Cap
6,044 Cr
P/E: 33.1x
Industry P/E: 32.9x
Fundamentals
Sales (Cr) ₹ 715
Growth 8.6%
EBITDA 36.1%
P/S 8.5x
Dividend 0.1%
P/E 33.1x
Book Value ₹ 2
PEG Ratio 3.8x
ROE 999.0%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.
Belongs to (10 Indices) view more
Investors (5)
jyotsana
rajeev4
shivani....
Followers (1)
varsha96